Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumigan versus Xalatan crossover study in primary therapy for open-angle glaucoma and ocular hypertension
2004-002979-16Phase 4Completed
- Sponsor
- Cardiff University
- Start
- Feb 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bimatoprost and latanoprost in open-angle glaucoma (OAG), ocular hypertension, pseudoexfoliation glaucoma (PXG) and 1 more (2 arms), sponsored by Cardiff University. Primary endpoints: Lowering of intraocular pressure from baseline after first medication, Lowering of intraocular pressure from baseline after second medication and 1 more. Started Feb 2005; status: completed.
02
Drugs
bimatoprostlatanoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertensionpseudoexfoliation glaucoma (PXG)pigment dispersion syndrome (PDS)
Beyond the preview
Go deeper on 2004-002979-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002979-16.